Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.31 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.31 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.31 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9282194 | 0.98 | CYP3A4 (0.35) | CYP3A4 | |
| SCHEMBL3313925 | 0.75 | — | — | |
| SCHEMBL3313929 | 0.75 | CYP3A4 (0.38) | CYP3A4MEN1USP2TNNI3TNNT2 | |
| SCHEMBL10602865 | 0.63 | ALDH1A1 (0.51) | MEN1KMT2A | |
| SCHEMBL8640814 | 0.57 | KMT2A (0.43) | CYP3A4MEN1USP2TNNI3TNNT2 | |
| SCHEMBL20861812 | 0.57 | CYP3A4 (0.46) | CYP3A4MEN1KMT2A | |
| SCHEMBL8027716 | 0.57 | CYP3A4 (0.35) | CYP3A4MEN1KMT2A | |
| Iodide SCHEMBL9358702 | 0.56 | CYP3A4 (0.31) | CYP3A4 | |
| SCHEMBL5474378 | 0.56 | CYP3A4 (0.34) | CYP3A4 | |
| SCHEMBL30646141 | 0.56 | CA1 (0.38) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0479463-B1 | Process for the production of carboxylic acid anhydrides | BP CHEM INT LTD (GB) | 1995-12-13 | — | — | EP | claimed |
| EP-0479463-A2 | Process for the production of carboxylic acid anhydrides | BP Chemicals Limited (GB) | 1992-04-08 | — | — | EP | claimed |
| JP-4257538-A | — | — | None | — | — | JP | disclosed |
| US-20090177007-A1 | PROCESS FOR PRODUCING CARBOXYLIC ACID ANHYDRIDES | CHINA PETROCHEMICAL DEVELOPMENT CORPORATION | 2009-07-09 | — | — | US | disclosed |
| US-7553991-B1 | Process for producing carboxylic acid anhydrides | CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) | 2009-06-30 | — | — | US | disclosed |
| EP-0584964-B1 | Process for the recovery of group VIII noble metals | BP CHEM INT LTD (GB) | 1998-08-26 | — | — | EP | disclosed |
| CN-1033698-C | Process for production of carboxylic cid anhydrides | BP CHEM INT LTD (GB) | 1997-01-01 | — | — | CN | disclosed |
| EP-0535825-B1 | Process for the purification of carboxylic acids and/or their anhydrides | BP CHEM INT LTD (GB) | 1996-05-08 | — | — | EP | disclosed |
| EP-0479463-B1 | Process for the production of carboxylic acid anhydrides | BP CHEM INT LTD (GB) | 1995-12-13 | — | — | EP | disclosed |
| US-5364822-A | Process for the recovery of group VIII noble metals | BP CHEMICALS LIMITED (GB) | 1994-11-15 | — | — | US | disclosed |
| US-5298586-A | Reacting carbon monoxide with carboxylic acid, ester or alkyl ether in presence of rhodium catalyst and iodide promoter | BP CHEMICALS LIMITED (GB) | 1994-03-29 | — | — | US | disclosed |
| US-5298586-A | Reacting carbon monoxide with carboxylic acid, ester or alkyl ether in presence of rhodium catalyst and iodide promoter | BP CHEMICALS LIMITED (GB) | 1994-03-29 | — | — | US | disclosed |
| EP-0584964-A1 | Process for the recovery of group VIII noble metals | BP Chemicals Limited (GB) | 1994-03-02 | — | — | EP | disclosed |
| US-5227520-A | Distillation, iodide promoter, rhodium catalyst | BP CHEMICALS LIMITED (GB) | 1993-07-13 | — | — | US | disclosed |
| EP-0535825-A2 | Process for the purification of carboxylic acids and/or their anhydrides | BP Chemicals Limited (GB) | 1993-04-07 | — | — | EP | disclosed |
| JP-H04257538-A | PRODUCTION OF CARBOXYLIC ANHYDRIDE | BP CHEM INTERNATL LTD | 1992-09-11 | — | — | JP | disclosed |
| EP-0479463-A2 | Process for the production of carboxylic acid anhydrides | BP Chemicals Limited (GB) | 1992-04-08 | — | — | EP | disclosed |
| EP-0479463-A2 | Process for the production of carboxylic acid anhydrides | BP Chemicals Limited (GB) | 1992-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090177007-A1 | PROCESS FOR PRODUCING CARBOXYLIC ACID ANHYDRIDES | CA9, CA4, CA6 | CYP3A4 111/4885MEN1 4479/4885USP2 1074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.